Research Excellence Award: Waquar Ahsan

Waquar Ahsan – Jazan University, College of Pharmacy, Saudi Arabia

Waquar Ahsan
Researcher	Waquar Ahsan
Affiliation	Jazan University
Country	Saudi Arabia
Scopus ID	24605168800
Documents	115
Citations	3,288
h-index	33
Subject Area	Drug Discovery and Development
Event	International Top Pharmaceutical Awards
ORCID	0000-0002-5987-2933

Waquar Ahsan is a pharmaceutical researcher affiliated with the College of Pharmacy at Jazan University, Saudi Arabia. His academic contributions encompass pharmaceutical chemistry, drug discovery, nanomedicine, formulation development and pharmacological investigations. His research profile reflects interdisciplinary engagement with emerging therapeutic technologies and pharmaceutical innovation. His scholarly record provides a foundation for consideration under the Research Excellence Award at the International Top Pharmaceutical Awards. [1]

1. Abstract

This article presents the academic and research contributions of Waquar Ahsan in pharmaceutical sciences, with particular emphasis on drug discovery and development. His documented publications cover nanostructured drug delivery systems, anticancer formulations, molecular interactions and therapeutic applications of pharmaceutical compounds. These research areas demonstrate an interdisciplinary approach connecting pharmaceutical chemistry, formulation science and biomedical research. His scholarly activities provide relevant evidence for recognition of research contributions and scientific advancement. [2]

2. Keywords

Waquar Ahsan; Research Excellence Award; Drug Discovery and Development; Pharmaceutical Chemistry; Nanomedicine; Drug Delivery Systems; Pharmaceutical Formulation; Anticancer Research; Molecular Docking; Pharmacological Research.

3. Introduction

Drug discovery and development involve interconnected scientific disciplines focused on identifying therapeutic candidates, optimizing formulations and investigating their biological properties. Research in these areas contributes to the development of innovative pharmaceutical approaches and improved drug delivery strategies. Waquar Ahsan’s publication record includes investigations addressing pharmaceutical formulations, natural compounds, nanotechnology-based interventions and potential therapeutic applications, reflecting the multidisciplinary character of contemporary pharmaceutical research. [3]

4. Research Profile

According to his ORCID record, Waquar Ahsan is associated with the College of Pharmacy at Jazan University, Saudi Arabia, as an Associate Professor of Pharmaceutical Chemistry. His registered scholarly activities include journal articles and research contributions across pharmaceutical and biomedical disciplines. His ORCID profile also documents his Scopus Author ID and research outputs, supporting the identification and verification of his academic publications. [1]

5. Research Contributions

Additional contributions concern therapeutic deep eutectic systems and pharmaceutical delivery applications. His collaborative research also addresses natural compounds, molecular docking and pharmacological investigations. Such research themes are relevant to exploring formulation optimization, compound characterization and potential therapeutic mechanisms. They demonstrate the connection between pharmaceutical chemistry and emerging approaches to drug discovery and development. [5]

6. Publications

His documented publications include Development of erlotinib-loaded nanotransferosomal gel for the topical treatment of ductal carcinoma in situ, published in Nanomedicine (2024), and Development of nanobigel system combining apoptosis-inducing daidzein and flaxseed oil for the synergistic treatment of skin cancer, published in the Journal of Drug Delivery Science and Technology (2024). Both publications address nanotechnology-assisted pharmaceutical formulation research. [3] [4]

7. Research Impact

The research record demonstrates contributions across pharmaceutical chemistry, drug delivery, nanomedicine and therapeutic investigations. His collaborative publications provide scientific perspectives on formulation development and potential applications of pharmaceutical compounds. The reported citation indicators further offer measurable evidence of scholarly visibility. Continued research into advanced delivery platforms and therapeutic candidates may contribute to future developments in pharmaceutical and biomedical sciences. [2] [4]

8. Award Suitability

Waquar Ahsan’s research activities demonstrate relevance to the Research Excellence Award through documented publications, interdisciplinary pharmaceutical investigations and contributions to nanotechnology-assisted drug delivery research. His reported bibliometric indicators provide additional quantitative context for academic evaluation. His research profile aligns with the award’s emphasis on scientific contributions, pharmaceutical innovation and scholarly advancement within drug discovery and development. [1] [2]

9. Conclusion

Waquar Ahsan’s academic profile reflects sustained engagement with pharmaceutical chemistry, nanomedicine and drug discovery research. His documented publications demonstrate collaborative contributions to advanced formulations and potential therapeutic applications. The combination of research outputs, interdisciplinary interests and reported scholarly indicators establishes a relevant academic profile for consideration under the Research Excellence Award presented by the International Top Pharmaceutical Awards.

10. External Links

• ORCID Researcher Profile
• Scopus Author Profile
• International Top Pharmaceutical Awards

11. References

1. Elsevier. (n.d.). Scopus author details: Waquar Ahsan, Author ID 24605168800. Scopus.
   https://www.scopus.com/authid/detail.uri?authorId=24605168800
2. Mangla, B., Mittal, P., Kumar, P., Javed, S., Ahsan, W., and Aggarwal, G. (2024). Development of erlotinib-loaded nanotransferosomal gel for the topical treatment of ductal carcinoma in situ. Nanomedicine.
   DOI: 10.2217/nnm-2023-0260
3. Mangla, B., Kaur, A., Kumar, P., Javed, S., Ahsan, W., and Popli, H. (2024). Development of nanobigel system combining apoptosis-inducing daidzein and flaxseed oil for the synergistic treatment of skin cancer. Journal of Drug Delivery Science and Technology.
   DOI: 10.1016/j.jddst.2024.105843
4. Javed, S., Mangla, B., Sultan, M. H., Almoshari, Y., Sivadasan, D., Madkhali, O. A., and Ahsan, W. (2024). Pharmaceutical applications of therapeutic deep eutectic systems (THEDES) in maximising drug delivery. Heliyon.
   DOI: 10.1016/j.heliyon.2024.e29783
5. Khalid, A., Khan, W., Zia, K., Azizuddin, Ahsan, W., and collaborators. (2023). Natural coumarins from Murraya paniculata as mixed-type inhibitors of cholinesterases: In vitro and in silico investigations. Frontiers in Pharmacology.
   DOI: 10.3389/fphar.2023.1133809